-
181
-
182
-
183
-
184
-
185
-
186
-
187
-
188
Mechlorethamine Hydrochloride Gel in the Treatment of Mycosis Fungoides–Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Focus on Patient Selection and Special Considerations
Published 2022-11-01“…Caitlin Crimp,1 Ameya Gangal,2 Erica S Tarabadkar,3 Michi M Shinohara1,4 1Division of Dermatology, University of Washington, Seattle, WA, USA; 2School of Medicine, Emory University, Atlanta, GA, USA; 3Department of Dermatology, Emory University School of Medicine; Winship Cancer Institute, Atlanta, GA, USA; 4Fred Hutchinson Cancer Center, Seattle, WA, USACorrespondence: Michi M Shinohara, University of Washington, 1959 NE Pacific St., Box 356524, Seattle, WA, 98195, USA, Tel +1 206-616-8523, Fax +1 206-598-4768, Email mshinoha@uw.eduAbstract: Mycosis fungoides (MF) is the most common type of cutaneous T-cell lymphoma (CTCL) and often has an indolent course, particularly for patients presenting with early-stage (patch/plaque) disease. …”
Get full text
Article -
189
-
190
-
191
Long non-coding RNA in glioma: novel genetic players in temozolomide resistance
Published 2023-12-01Get full text
Article -
192
-
193
-
194
Addressing disparities in cancer clinical trials: a roadmap to more equitable accrual
Published 2024-03-01Get full text
Article -
195
-
196
-
197
icuARM-An ICU Clinical Decision Support System Using Association Rule Mining
Published 2013-01-01Get full text
Article -
198
-
199
-
200
Statin drugs enhance responses to immune checkpoint blockade in head and neck cancer models
Published 2023-01-01Get full text
Article